http://surgerybook.net/

117. Eldrup-Jorgensen J, Flanigan DP, Brace L, et al. Hypercoagulable states and lower limb ischemia in

young adults. J Vasc Surg 1989;9:334–341.

118. Vermylen J, Blockmans D, Spitz B, et al. Thrombosis and immune disorders. Clin Haematol

1986;15:393–412.

119. Ferro D, Pittoni V, Quintarelli C, et al. Coexistence of anti-phospholipid antibodies and endothelial

perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state. Circulation

1997;95:1425–1432.

120. Rand JH, Wu XX, Andree HA, et al. Pregnancy loss in the antiphospholipid-antibody syndrome–a

possible thrombogenic mechanism. N Eng J Med 1997;337:154–160.

121. Reverter JC, Tassies D, Font J, et al. Hypercoagulable state in patients with antiphospholipid

syndrome is related to high induced tissue factor expression on monocytes and to low free protein

S. Arterioscler Thromb Vasc Biol 1996;16:1319–1326.

122. Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. Eng J Med

2013;368:1033–1044.

123. Greenfield LJ. Lupus-like anticoagulants and thrombosis. J Vasc Surg 1988; 7:818–819.

124. Ahn SS, Kalunian K, Rosove M, et al. Postoperative thrombotic complications in patients with lupus

anticoagulant: increased risk after vascular procedures. J Vasc Surg 1988;7:749–756.

125. Nielsen TG, Nordestgaard BG, von Jessen F, et al. Antibodies to cardiolipin may increase the risk of

failure of peripheral vein bypasses. Eur J Vasc Endovasc Surg 1997;14:177–184.

126. Miyakis S, Lockshin M, Atsumi T, et al. International consensus statement on an update of the

classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–

306.

127. Lynch A, Marlar R, Murphy J, et al. Antiphospholipid antibodies in predicting adverse pregnancy

outcome. A prospective study. Ann Intern Med 1994;120:470–475.

128. Alving BM. How I treat heparin-induced thrombocytopenia and thrombosis. Blood 2003;101:31–37.

129. Ansell JE, Price JM, Shah S, et al. Heparin-induced thrombocytopenia. What is its real frequency?

Chest 1985;88:878–882.

130. Cancio LC, Cohen DJ. Heparin-induced thrombocytopenia and thrombosis. J Am Coll Surg

1998;186:76–91.

131. Almeida JI, Coats R, Liem TK, et al. Reduced morbidity and mortality rates of the heparin-induced

thrombocytopenia syndrome. J Vasc Surg 1998; 27:309–314; discussion 315–316.

132. Kelton JG, Smith JW, Warkentin TE, et al. Immunoglobulin G from patients with heparin-induced

thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994;83:3232–3239.

133. Walenga JM, Jeske WP, Messmore HL. Mechanisms of venous and arterial thrombosis in heparininduced thrombocytopenia. J Thromb Thrombolysis 2000;10(suppl 1):13–20.

134. Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: the antibody is

not heparin specific. Thromb Haemost 1992; 67:545–549.

135. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated

with low-molecular-weight heparin or unfractionated heparin. N Eng J Med 1995;332:1330–1335.

136. Laster J, Silver D. Heparin-coated catheters and heparin-induced thrombocytopenia. J Vasc Surg

1988;7:667–672.

137. Levine RL, McCollum D, Hursting MJ. How frequently is venous thromboembolism in heparintreated patients associated with heparin-induced thrombocytopenia? Chest J 2006;130:681–687.

138. Warkentin TE. Heparin-induced thrombocytopenia. Dis Mon 2005;51:141–149.

139. Cuker A, Gimotty PA, Crowther MA, et al. Predictive value of the 4Ts scoring system for heparininduced thrombocytopenia: a systematic review and meta-analysis. Blood 2012;120:4160–4167.

140. Pouplard C, Gueret P, Fouassier M, et al. Prospective evaluation of the ‘4Ts’ score and particle gel

immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J

Thromb Haemost 2007;5:1373–1379.

141. Warkentin TE. Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost

1999;82:439–447.

142. Anderson JA, Weitz JI. Hypercoagulable states. Crit Care Clin 2011;27:933–952; vii.

143. Nakashima MO, Rogers HJ. Hypercoagulable states: an algorithmic approach to laboratory testing

164